(redirected from Poly-N-Acetyl Glucosamine)
PNAGPoly-N-Acetyl Glucosamine (antigen)
References in periodicals archive ?
US-based vaccine developer Alopexx Vaccine LLC has completed a Phase 1 clinical trial with AV0328, a vaccine targeting the broadly expressed microbial antigen, poly-N-acetyl glucosamine (PNAG), the company said.
This single-cell organism extrudes a polymer called poly-N-acetyl glucosamine.
However, researchers can easily obtain large amounts of pure poly-N-acetyl glucosamine by growing alga in the laboratory.